With AI-related cryptocurrencies gaining momentum, several projects have seen increased market activity and user adoption.

Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the ...

Skyward Specialty also announced the following fourth quarter 2024 preliminary results and provided 2025 guidance: Highlights for the fourth quarter included: Gross written premiums of $388.4 million, ...

Houston-headquartered Skyward Specialty Insurance Group Inc has commuted a loss portfolio transfer and adverse development ...

Skyward Specialty Insurance Group, Inc. has commuted the Loss Portfolio Transfer and Adverse Development and Retrocession ...

AM Best has affirmed the Financial Strength Rating of A+ (Superior) and the Long-Term Issuer Credit Rating of "aa-" (Superior ...

MIAMI--(BUSINESS WIRE)--LPT is proud to announce that Mercedes Saewitz, a highly accomplished real estate professional with over 20 years of experience, has joined the company as Senior Vice ...

The Company received $11.7 million in cash. Additionally, at December 31, 2024 the Company strengthened LPT loss reserves by $25.3 million and recognized approximately $9.8 million, net of tax ...

This is the second successful treatment in a donkey, demonstrating the potential of Innocan's Liposomal CBD injection for ...